IRMD · Iradimed Corp · Webcasts, Transcripts & Audio
$83.95
-0.68 (-0.80%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$1.08B
Shares
12.79M
Volume · Oct 27
127.15K
Avg daily vol (3M)
123.45K
Iradimed Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Iradimed Corp (IRMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-07-31
Iradimed Corp (IRMD) Q2 2026 Earnings Call Transcript
Confident tone
3870 IV Pump Production Ramp
Financial Guidance and Margin Outlook
3870 Replacement Opportunity / Channel Growth
Revenue
$20.47M
▲ 0.3% YoY Diluted EPS
$0.41
▼ 8.9% YoY Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-01
Iradimed Corp (IRMD) Q1 2026 Earnings Call Transcript
Confident tone
3870 MR IV Pump Launch
MRI-Compatible IV Infusion Pump Revenue
Replacement Opportunity of 3860 Installed Base
Revenue
$21.98M
▲ 12.6% YoY Diluted EPS
$0.45
▲ 21.6% YoY Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Iradimed Corp (IRMD) Q4 2025 Earnings Call Transcript
Confident tone
3870 MR IV Pump Launch
Replacement Opportunity / Pump Channels
Gross Margin Outlook
Revenue
$22.69M*
▲ 17% YoY Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Iradimed Corp (IRMD) Q3 2025 Earnings Call Transcript
Confident tone
3870 MRI IV Pump Launch
Gross Margin and Manufacturing Transition
International Regulatory Path
Revenue
$21.20M
▲ 15.7% YoY Diluted EPS
$0.43
▲ 7.5% YoY Gross margin
77.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-01
Iradimed Corp (IRMD) Q2 2025 Earnings Call Transcript
Confident tone
3870 IV pump FDA clearance and launch
Gross margin and ASP on new pump
Quarterly and full-year revenue and earnings guidance raise
Revenue
$20.41M
▲ 13.8% YoY Diluted EPS
$0.45
▲ 18.4% YoY Gross margin
78.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Iradimed Corp (IRMD) Q1 2025 Earnings Call Transcript
Confident tone
Disposables growth
Financial guidance and results
FDA 510(k) clearance for 3870 pump
Revenue
$19.51M
▲ 10.9% YoY Diluted EPS
$0.37
▲ 15.6% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Iradimed Corp (IRMD) Q4 2024 Earnings Call Transcript
Confident tone
Tariffs and supply chain exposure
Record financial results and growth
Pump replacement / installed base opportunity
Revenue
$19.39M*
▲ 11.1% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Iradimed Corp (IRMD) Q3 2024 Earnings Call Transcript
Confident tone
Quarterly Revenue and Earnings Records
New 510(k) Pump Progress and FDA Clearance
Sales Force Expansion Planning
Revenue
$18.33M
▲ 11% YoY Diluted EPS
$0.40
▲ 0% YoY Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Iradimed Corp (IRMD) Q2 2024 Earnings Call Transcript
Confident tone
Legacy 3860 pump demand and backlog
New 3870 IV pump and FDA 510(k) clearance
FMD device adoption
Revenue
$17.93M
▲ 11.1% YoY Diluted EPS
$0.38
▲ 15.2% YoY Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Iradimed Corp (IRMD) Q1 2024 Earnings Call Transcript
Confident tone
Disposables backlog and lead times
Financial guidance
New 3870 MRI IV Pump 510(k) submission
Revenue
$17.60M
▲ 13.7% YoY Diluted EPS
$0.32
▲ 18.5% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Iradimed Corp (IRMD) Q4 2023 Earnings Call Transcript
Confident tone
New 3850 MRI IV pump / FDA 510(k) submission
Gross margin outlook
2024 financial guidance
Revenue
$17.45M*
▲ 17.4% YoY Gross margin
76.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Iradimed Corp (IRMD) Q3 2023 Earnings Call Transcript
Revenue
$16.50M
▲ 23.1% YoY Diluted EPS
$0.40
▲ 48.1% YoY Gross margin
77.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Iradimed Corp (IRMD) Q2 2023 Earnings Call Transcript
Revenue
$16.13M
▲ 26.8% YoY Diluted EPS
$0.33
▲ 26.9% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Iradimed Corp (IRMD) Q1 2023 Earnings Call Transcript
Revenue
$15.48M
▲ 25.7% YoY Diluted EPS
$0.27
▲ 35% YoY Gross margin
75.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-19
Iradimed Corp (IRMD) Q4 2022 Earnings Call Transcript
Revenue
$14.86M*
▲ 25.2% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Iradimed Corp (IRMD) Q3 2022 Earnings Call Transcript
Revenue
$13.41M
▲ 22.9% YoY Diluted EPS
$0.27
▲ 35% YoY Gross margin
78.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-29
Iradimed Corp (IRMD) Q2 2022 Earnings Call Transcript
Revenue
$12.72M
▲ 29.7% YoY Diluted EPS
$0.26
▲ 116.7% YoY Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-29
Iradimed Corp (IRMD) Q1 2022 Earnings Call Transcript
Revenue
$12.31M
▲ 33.5% YoY Diluted EPS
$0.20
▲ 81.8% YoY Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-04
Iradimed Corp (IRMD) Q4 2021 Earnings Call Transcript
Revenue
$11.87M*
▲ 38.9% YoY Gross margin
77.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-29
Iradimed Corp (IRMD) Q3 2021 Earnings Call Transcript
Revenue
$10.91M
▲ 41.7% YoY Diluted EPS
$0.20
▲ 122.2% YoY Gross margin
77.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-30
Iradimed Corp (IRMD) Q2 2021 Earnings Call Transcript
Revenue
$9.81M
▲ 44.4% YoY Diluted EPS
$0.12
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-30
Iradimed Corp (IRMD) Q1 2021 Earnings Call Transcript
Revenue
$9.22M
▲ 6.3% YoY Diluted EPS
$0.11
▼ 21.4% YoY Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Iradimed Corp (IRMD) Q4 2020 Earnings Call Transcript
Revenue
$8.55M*
▼ 21.5% YoY Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-30
Iradimed Corp (IRMD) Q3 2020 Earnings Call Transcript
Revenue
$7.70M
▼ 22.7% YoY Diluted EPS
$0.09
▼ 55% YoY Gross margin
74.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Iradimed Corp (IRMD) Q2 2020 Earnings Call Transcript
Revenue
$6.79M
▼ 26.3% YoY Diluted EPS
$-0.17
▼ 200% YoY Gross margin
72.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Iradimed Corp (IRMD) Q1 2020 Earnings Call Transcript
Revenue
$8.68M
▲ 2.8% YoY Diluted EPS
$0.14
▼ 6.7% YoY Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-06
Iradimed Corp (IRMD) Q4 2019 Earnings Call
Revenue
$10.89M*
▲ 30.6% YoY Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 webcasts
Key facts
CIK
1325618
CUSIP
46266A109
13F (30d)
43 filings
38 filers
Visit website
Investor relations